✨ Free AI Report
Quanterix Corporation: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Quanterix Corporation
Company Research

Quanterix Corporation: Business Overview, Financials & Competitive Analysis

Quanterix is a life sciences company that develops and markets digital immunoassay platforms advancing precision health for life sciences research and diagnostics across North America, Europe, Middle East, Africa, and...

Analyst-debate audio for Quanterix Corporation

AskCyborg analysts argue the bull and bear cases for Quanterix Corporation across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
6/ 10Solid

Cyborg Score thesis

Emerging leader in ultra-sensitive biomarker detection with strong revenue growth trajectory, strategic FDA submissions, and...

Read the full analyst-debate transcript →
Industry Life Sciences / In-Vitro Diagnostics / Biomarker Detection Technology
3 named competitors
4 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: October 19, 2026
AI-Generated Research
30+ Page Report

Get the Latest Quanterix Corporation Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Quanterix Corporation Overview

Pro stress-test →

Quanterix is a life sciences company that develops and markets digital immunoassay platforms advancing precision health for life sciences research and diagnostics across North America, Europe, Middle East, Africa, and Asia Pacific regions. The company develops ultra-sensitive detection systems for use in research and in-vitro diagnostics.

Strategic Profile

Pro stress-test →

The company operates a consumable-based revenue model providing recurring revenue and high margins as the installed base of Simoa instruments grows. The company primarily operates in neurology, oncology, immunology, and inflammation, with focus on selling to academic/governmental research institutions, pharmaceutical, biotechnology, and contract research companies through direct sales and distributors.

Competitive Landscape

Pro stress-test →

According to 3 analysts, the average rating for QTRX is "Hold" with 12-month stock price target of $10.33 representing 35.74% upside from latest price. Quanterix competes in the biomarker diagnostics and ultra-sensitive detection space against established in-vitro diagnostics companies and emerging precision health platforms.

Industry Context

Quanterix Corporation operates in Life Sciences / In-Vitro Diagnostics / Biomarker Detection Technology.

Key facts

Founded: 2007 · Headquarters: Billerica, Massachusetts, US · Revenue: $137.4M (2024) · Market cap: $0.22B

What the AI analysts debated

AI-generated and not independently verified: selected findings from the multi-agent debate on Quanterix Corporation.

  • Quanterix appointed Everett Cunningham as President and CEO effective January 19, 2026, with company expecting to exceed revenue and cash guidance for full year 2025
  • The company announced FDA 510(k) submission for multi-analyte algorithmic blood test for Alzheimer's disease detection in February 2026
+2 more AI-generated counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • February 2026FDA 510(k) submission for multi-analyte Alzheimer's disease blood test
  • January 2026New CEO appointment - Everett Cunningham; exceeded 2025 revenue and cash guidance
  • +2 moreTrack every material event for Quanterix Corporation as it happens. Explore monitoring →
Get alerted when Quanterix Corporation has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Digital BiomarkersEstablished competitor in immunoassay and molecular diagnostics→Blood-Based BiomarkersMajor player in blood screening and diagnostic platforms→Immunoassay PlatformsLarge-cap competitor in automated immunoassay systems→

Compare Quanterix Corporation with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Quanterix Corporation operates in Life Sciences / In-Vitro Diagnostics / Biomarker Detection Technology. See how the rest of the sector scores on the Cyborg framework.

Browse Life Sciences / In-Vitro Diagnostics / Biomarker Detection Technology research →
NEW · MCP server

Ask your AI assistant about Quanterix Corporation

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Quanterix Corporation and its top competitor on Cyborg Score”
“What did Quanterix Corporation do this quarter?”
“Is Quanterix Corporation a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg research is made

⚔

AI analyst debate, not single-author opinion

Every report is generated by a panel of AI analysts arguing across 11 dimensions, so counter-arguments sit alongside the case. The debate is a reasoning process; it does not independently verify facts.

📊

Dated, not live

The Cyborg Score and recent developments reflect public sources as of the date shown and can miss or lag recent events. Check primary sources before relying on them.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The Cyborg Score is an AI-generated opinion under that framework, not a credit rating or an investment recommendation.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, and news flow, analysed by AI models. Read the methodology →

AI-generated research summary based on public sources; it may contain errors or omissions. Not investment advice. Not reviewed or endorsed by the companies covered. Report an error: legal@askcyborg.com · Terms of Service

Frequently asked questions

What does Quanterix Corporation do?+
Quanterix is a life sciences company that develops and markets digital immunoassay platforms advancing precision health for life sciences research and diagnostics across North America, Europe, Middle East, Africa, and...
What is Quanterix Corporation's Cyborg Score?+
Quanterix Corporation has a Cyborg Score of 6/10 (Solid). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Quanterix Corporation's main competitors?+
Named competitors include Digital Biomarkers, Blood-Based Biomarkers, Immunoassay Platforms. The full competitive landscape is in the AskCyborg report.
How can I get the full Quanterix Corporation research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Quanterix Corporation research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Quanterix Corporation over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

More Life Sciences research

Companies in the same sector and named competitors, ranked by Cyborg Score.

8Danaher Corporation8Thermo Fisher Scientific Inc.7Repligen Corporation6iSpecimen Inc.6Nautilus Biotechnology, Inc.4Seer Inc